Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor.
García-Valverde A, Rosell J, Serna G, Valverde C, Carles J, Nuciforo P, Fletcher JA, Arribas J, Politz O, Serrano C.
García-Valverde A, et al. Among authors: serrano c.
Mol Cancer Ther. 2020 Jun;19(6):1289-1297. doi: 10.1158/1535-7163.MCT-19-1069. Epub 2020 May 5.
Mol Cancer Ther. 2020.
PMID: 32371592